Imprint

Imprint is developing scalable experimental and computational tools to decode the body’s immune memory by reconstructing immune histories from B cells and T cells. Their goal is to uncover hidden causes of chronic diseases—such as autoimmune conditions, long COVID, psychiatric disorders, and dementia—by identifying “trigger-target” relationships between infections/exposures and disease onset. The company has raised $15 million in philanthropic funding to build high-throughput data generation pipelines and open-access computational platforms. No clinical results or therapeutics have been reported; the focus is on enabling discovery through technology.